Introduction
Mouse oocytes are terminally differentiated cells that can express genes, but not replicate them (Schultz, 1993;  Regulation of transcription involves at least two primary Majumder and DePamphilis, 1994b, 1995) . Transcription cis-acting DNA sequence components: promoters (short stops when oocytes undergo meiotic maturation to form distance) and enhancers (long distance). Promoters deterunfertilized eggs. Fertilization triggers completion of mine where transcription begins; they function upstream meiosis and formation of a one-cell embryo containing a and proximal to the initiation site and consist of a binding haploid paternal pronucleus derived from the sperm and site for the basal level transcription complex and often a haploid maternal pronucleus derived from the oocyte. one or more sequence-specific transcription factor binding Each pronucleus then undergoes DNA replication before sites. Enhancers stimulate weak promoters in a tissueentering the first mitosis to produce a two-cell embryo specific manner; they consist of sequence-specific trancontaining two diploid 'zygotic' nuclei, each with a set scription factor binding sites that function distal to the of paternal and a set of maternal chromosomes. Although initiation site from either an upstream or downstream position (Felsenfeld, 1992; Workman and Buchman, 1993;  a transcriptionally permissive state occurs at the late one-cell stage in mouse development (Latham et al., 1992) , not be relieved by enhancers such as the polyomavirus F101 or SV40 enhancers that function effectively in zygotic gene expression (ZGE) is regulated by a timedependent mechanism ('zygotic clock') that delays trancleavage-stage embryos (Chalifour et al., 1986; Martínez-Salas et al., 1989; Majumder et al., 1993;  Wiekowski scription of zygotic genes and translation of nascent mRNA until a specified time (~40 h) after fertilization, et al., 1993) . These enhancers could alleviate repression only after formation of a two-cell embryo, regardless of which corresponds to the two-cell stage of normally developing embryos (Conover et al., 1991; Schultz, 1993;  whether the resulting cleavage-stage embryos continue morphological development or are arrested in S-phase Majumder and DePamphilis, 1995; Nothias et al., 1995 Nothias et al., , 1996 Majumder, 1997) . However, when one-cell embryos (Majumder et al., 1993; Wiekowski et al., 1993) . Thus, while stimulation by enhancers requires the presence of are arrested in S-phase, ZGE still occurs~40 h after fertilization, even though morphological development has chromatin-mediated repression, this repression alone is not sufficient to elicit enhancer function. Experiments ceased. This phenomenon has facilitated dissection of the pathway regulating ZGE at the beginning of mammalian described in this paper demonstrate that enhancer function requires the presence of a coactivator activity in addition development.
Injection of plasmid-encoded genes into the nuclei of to the presence of promoter repression, and enhancer activation proteins. Furthermore, the absence of this mouse oocytes, one-cell and two-cell embryos has revealed that transcription always requires a functional eukaryotic coactivator activity prior to formation of a two-cell mouse embryo, would help to prevent premature transcription of promoter, but that stimulation of promoters or origins by enhancers does not appear until formation of a two-cell zygotic genes, while its presence after zygotic gene activation would help to regulate the activity of groups of embryo (Martínez-Salas et al., 1989; Majumder et al., 1993; Wiekowski et al., 1993; genes that depend on enhancers. Thus, it may serve as a critical regulator in ZGE. 1995; Nothias et al., 1996; Majumder, 1997) . This developmental acquisition of enhancer function is not due to differences in the amount or composition of transcription
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factors required for promoter activity in two-cell embryos (Majumder et al., 1993) , nor is it due to the formation of Enhancer stimulation of promoters first appears in two-cell embryos a zygotic nucleus (Wiekowski et al., 1993; Henery et al., 1995) . It does, however, require the presence of chromatinPreviously we observed that the activity of weak promoters is very high in the paternal pronucleus of one-cell embryos, mediated repression. This repression can be relieved by addition of butyrate to the cell culture medium (Majumder and is repressed in the zygotic nuclei of two-cell embryos. The promoter repression in two-cell embryos could be et Wiekowski et al., 1993) . Butyrate inhibits histone deacetylase, causing destabilization in the chrorelieved by the presence of an enhancer, or a transactivator, and that enhancers or transactivators had little effect in matin of mammalian cells (Grunstein, 1990; Turner, 1991) . Thus, based on the relative levels of promoter activity the paternal pronucleus of one-cell embryos. This led us to propose that the role of enhancers in vivo is to and the ability of butyrate to stimulate promoter activity, chromatin-mediated repression is found to be present in relieve promoter repression (Martínez-Salas et al., 1989; Wiekowski et al., 1991; Majumder et al., 1993;  Majumder the maternal nucleus of oocytes and one-cell embryos, and the zygotic nuclei and cytoplasm of two-to eightand DePamphilis, 1994a). Here, we extended these studies to mouse oocytes. In order to determine the relative cell embryos, but repression is absent from the paternal pronucleus of one-cell embryos (Majumder et al., 1993;  promoter and enhancer activities in oocytes and two-cell embryos, plasmid DNA (ptkluc or pF101tkluc) containing Wiekowski et al., 1993; Henery et al., 1995) . Furthermore, the ability to repress transcription after formation of a the firefly luciferase (luc) reporter gene placed under the control of herpes simplex virus (HSV) thymidine kinase two-cell embryo correlates with changes in histone synthesis and modification (Wiekowski et al., 1997) . In (tk) promoter, linked or unlinked to the polyomavirus F101 enhancer (F101) was injected into the germinal addition, plasmid DNA injected into oocytes and two-to four-cell embryos, and not into paternal pronuclei of vesicle of oocytes and one of the zygotic nuclei of twocell embryos. In order to determine the effect of a one-cell embryos, is rapidly assembled into chromatin (Martínez-Salas et al., 1989) . Butyrate strongly stimulates transactivator, ptkluc was also co-injected with an expression vector (pMEX4) encoding the HSV transactivator, promoter activity in cleavage-stage embryos, but has little effect on promoters that are already stimulated by an ICP4. The tk promoter and F101 enhancer were selected because they use cellular transcription factors exclusively enhancer (Majumder et al., 1993; Wiekowski et al., 1993) . Inhibition of histone deacetylase with either butyrate, and function in a wide variety of mouse cell types, including undifferentiated embryonic stem cells and trichostatin A or trapoxin increases the amount of nuclear hyperacetylated histone H4 in two-to eight-cell embryos cleavage-stage embryos (McKnight and Kingsbury, 1982; Martínez-Salas et al., 1989; Majumder et al., 1993; (Thompson et al., 1995; Worrad et al., 1995; Wiekowski et al., 1997) , consistent with the effect of these inhibitors Majumder and DePamphilis, 1994a) . HSV tk promoter has been found to respond to stimulation by various on promoter activity either in injected plasmids (Majumder et al., 1993; Wiekowski et al., 1993) or in transgenes enhancers and transactivators, including the F101 enhancer and the HSV-ICP4 transactivator (Stow and Stow, 1986; (Thompson et al., 1995) .
Although the promoter repression observed in the Boni and Coen, 1989; Majumder and DePamphilis, 1994a) . The F101 enhancer is the strongest enhancer found so far maternal pronucleus of S-phase-arrested one-cell embryos, like that observed in cleavage-stage embryos (two or more for stimulating promoter activity in two-to eight-cell mouse embryos (Mélin et al., 1993) . Enhancer elements cells), could be relieved by butyrate, this repression could enhancers or butyrate could relieve this repression. Therefore, to determine whether or not the promoter activity observed in oocytes resulted from chromatin-mediated repression, oocytes and two-cell embryos were isolated and cultured in the presence of butyrate and then injected with ptkluc. The results (Figure 1) showed that, at the same DNA concentration, tk promoter activity in oocytes was~5-fold lower than in two-cell embryos (Figure 1 ), but that tk promoter activity could be stimulated~15-fold by butyrate in both oocytes and two-cell embryos. These Absence of enhancer function in oocytes and one-cell (luc) under control of the HSV-tk promoter (ptkluc, s), and HSV-tk embryos could result either from insufficient amounts of promoter linked to the F101 enhancer (pF101tkluc, j). A promoterless control (pluc, n) was also tested. ptkluc was also coactivation proteins that bind to specific DNA sequences injected with 15 µg/ml pMEX4 (u), an expression vector for the within the enhancer, or from the absence of an enhancertransactivator HSV-ICP4 (Resnick et al., 1989) . Some of the oocytes specific coactivator, a protein that might mediate interand embryos injected with ptkluc were cultured in the presence of action between the enhancer-bound activation protein and 2.5 mM butyrate (d). Butyrate did not significantly increase luciferase gene expression with pluc. Luciferase activity was measured the promoter-bound transcription complex. To distinguish quantitatively in individual embryos or oocytes and expressed as light between these two possibilities, a tandem series of yeast units . Each data point indicates the mean value GAL4 DNA binding sites was used either as an enhancer Ϯ SEM for 40-60 successfully injected oocytes or embryos.
(GAL4 enhancer), placed 600 bp upstream of the tk promoter, driving the luciferase gene (pGAL 9 tkluc; Majumder et al., 1993) , or as a promoter (GAL4 promoter), were placed 600 bp upstream of the promoter. The plasmid pluc, containing the reporter gene without any promoter 10 bp upstream of a TATA box, driving the bacterial chloramphenicol acetyltransferase (CAT) gene (pGAL 5 -element, was used as a negative control in these experiments to determine the background level of luciferase TCAT; Majumder et al., 1993) . GAL4:VP16, a strong transcriptional activator that functions through GAL4 expression. Promoter/enhancer activity was quantitatively evaluated by their ability to express the luciferase gene.
DNA binding sites, was provided by co-injection of pSGVP, an expression vector that encodes the GAL4:VP16 Mouse oocytes were isolated and cultured in the presence of dibutyryl-cAMP to prevent meiotic maturation gene driven by the Sp1-dependent SV40 T-antigen promoter stimulated by the SV40 enhancer. The SV40 proand the inhibition of transcription that accompanies it. Two-cell embryos were isolated and cultured in the presmoter is very active in mouse oocytes and early embryos (Chalifour et al., 1986; Martínez-Salas et al., 1989 ; ence of aphidicolin in order to arrest development as they entered S-phase. When different amounts of plasmid Majumder et al., 1993) . The GAL4 promoter (pGAL 5 TCAT) alone was inactive ptkluc DNA were injected into these oocytes and embryos, the amount of luciferase activity observed was dependent when injected into oocytes, paternal (P) and maternal (M) pronuclei of S-phase-arrested one-cell embryos, or the on the amount of DNA injected (Figure 1 ), although the tk promoter activity in general was found to be~5-to 10-zygotic nuclei of two-cell embryos (Z). Co-injecting pGAL 5 TCAT with increasing amounts of pSGVP identifold lower in oocytes than in two-cell embryos. When pF101tkluc was introduced into oocytes and two-cell fied the amount of pSGVP required to provide saturating levels of functional GAL4:VP16 ( Figure 2A ; ϩGAL4: embryos, the promoter activity could be stimulated~15-fold in two-cell embryos, but not in oocytes. Similar VP16). GAL4 promoter activity was readily detected in all three cell types, but the maximum levels of activity results were also observed in oocytes and two-cell embryos when ptkluc was co-injected in the presence of pMEX4.
could vary up to 10-fold ( Figure 2A ). The ability of the GAL4 enhancer to stimulate the tk promoter was then These experiments suggest that enhancers or transactivators can stimulate promoters in two-cell embryos, but examined by co-injecting the enhancer construct, pGAL 9 -tkluc, with sufficient pSGVP to provide saturating amounts not in oocytes.
Previously, we found that incubating two-cell embryos of functional Gal4:VP16 protein. In the absence of GAL4:VP16, pGAL 9 tkluc and ptkluc (pGAL 9 tkluc withwith butyrate, a potent inhibitor of histone deacetylase, strongly stimulated the activity of plasmid-encoded proout the enhancer), produced the same level of luciferase.
In the presence of saturating levels of GAL4:VP16, moters (Majumder et al., 1993; Wiekowski et al., 1993) . Moreover, this stimulation was specific for promoters; however, the GAL4-dependent enhancer was active only after injection of two-cell embryos. This enhancer stimubutyrate did not increase the activity of promoters that were already stimulated by an enhancer. These and other lated tk promoter activity~30-fold in two-and four-cell embryos, but only 1-to 1.2-fold in oocytes, 1-to 2-fold experiments (see Introduction) suggested that the repression of promoter activity observed in two-cell embryos in the maternal pronuclei and 1-to 1.2-fold in the paternal pronuclei of one-cell embryos ( Figure 2B ). Thus, even in was mediated by chromatin structure, and that either either oocytes or two-cell embryos stimulated tk promoter activity~15-to 20-fold by relieving chromatin-mediated repression (Figures 1 and 2B) . Similarly, butyrate stimulated promoter activity in maternal pronuclei of one-cell embryos~4-to 5-fold ( Figure 2B ). When the promoter was already stimulated by an enhancer in two-cell embryos, then butyrate had little effect (see Figure 5 ; Majumder et al., 1993; Wiekowski et al., 1993) . [Note that the actual levels of expression from genes injected into oocytes and preimplantation embryos depend directly on the endogenous levels of transcription and translation of the injected cells. In fertilized eggs and cleavage-stage embryos, optimal levels are achieved by arresting these cells as they enter S-phase. In oocytes, optimal levels are achieved by injecting growing oocytes from young females (see Materials and methods).] Thus, if chromatin-mediated repression was all that was required to elicit enhancer function, then at a minimum, the GAL4 enhancer should have stimulated promoters~15-fold in oocytes and~5-fold in the maternal pronucleus of one-cell embryos. Therefore, a coactivator activity must be required for enhancer function that is absent in oocytes or one-cell embryos, and first appears with formation of a two- The lack of enhancer function in oocytes and one-cell arrested one-cell embryos and one of the zygotic nuclei (Z) of embryos is also valid for enhancers driven by endogenous aphidicolin-arrested two-cell embryos together with increasing transcription factors. Previous studies (Mélin et al., 1993) amounts of an expression vector for the transcription factor GAL4:VP16 (pSGVP). Oocytes, and one-and two-cell embryos were have shown that two copies of the 30 bp GTIIc sequence injected with a plasmid DNA solution containing 100 µg/ml encoding the TEF-1 DNA binding site are responsible for Sp1-dependent HSV tk promoter is also shown. This promoter was active in oocytes as well as in one-to eightcell embryos. The 3-to 4-fold greater activity observed the presence of saturating amounts of a functional sequence-specific enhancer activation protein, enhancer in S-phase-arrested one-cell embryos than in S-phasearrested two-cell embryos reflects the absence of repression function was not evident until formation of a two-cell embryo.
in paternal pronuclei of one-cell embryos. This difference would have been 10-fold had these two-cell embryos been This failure of enhancers to stimulate promoter activity prior to formation of a two-cell embryo was not due to injected with the same DNA concentration used for onecell embryos. Similar results were obtained using six limited transcriptional capacity of oocytes and S-phasearrested one-cell embryos, because addition of butyrate to tandem Sp1 sites as a promoter (Majumder et al., 1993) .
transcription factors (Figure 4 ). In these experiments, the total plasmid DNA concentration for each competition was constant, so that neither the amount of DNA, nor the expected level of luciferase expression arising from such an amount of injected DNA, nor the amount of luciferase produced, exceeded their saturating levels as previously determined (see Figure 2 in Majumder et al., 1993) . The test molecule used was pGT 5 Pyluc (GT enhancer), a plasmid encoding the luciferase gene driven by the polyomavirus T-antigen promoter stimulated by an enhancer consisting of five tandem copies of the TEF-1 DNA binding site placed 600 bp upstream of the promoter. When co-injected with an 8-fold excess of the enhancer construct, pF101tk (pF101tkluc with an inactivating internal deletion of the luciferase gene), into two-cell embryos, luciferase activity was reduced 12-fold. This resulted from competition for one or more trans-acting factors that limited luciferase gene expression. This limiting factor was specific for enhancer function, because competition with a different GAL4 enhancer construct, pGAL 9 tk (luciferase gene deleted) alone, did not interfere with luciferase gene expression unless saturating amounts of GAL4:VP16 were produced by co-injecting pSGVP, and thus activating the GAL4 enhancer. Under these conditions, luciferase gene activity was reduced 11-fold. Furthermore, if the tandem GAL4 DNA binding sites were used as a GAL4 promoter (pGAL 5 T) instead of a GAL4 enhancer, then in the presence of GAL4:VP16, GAL4 promoter inhibited the GT enhancer only 2.5-fold, plasm of mouse oocytes ( Figure 5 ). ES cells, like cleavagestage embryos, utilize the F101 enhancer efficiently (Mélin et al., 1993) , and therefore provided a convenient source Thus, sufficient TEF-1 activity was present in S-phasearrested one-cell embryos to drive a GT promoter, but not of mRNA encoding both the TEF-1 family of sequencespecific transcription factors and the putative enhancer a GT enhancer.
coactivator protein. Expression of coactivator activity in mouse oocytes was then assayed by co-injecting Enhancers compete with one another in two-cell embryos, but not in one-cell embryos pGAL 9 tkluc and pSGVP. As shown above, the tk promoter (ptkluc) was active in oocytes (Figures 1-3) where it The presence of an enhancer coactivator activity in mouse cleavage-stage embryos was further demonstrated by comcould be stimulated at least 15-fold by butyrate ( Figure  2B ). However, it could not be stimulated by the GAL4-petition experiments between enhancers whose activities did not depend upon binding the same sequence-specific dependent enhancer (pGAL 9 tkluc) in the presence of Fig. 4 . Enhancers can be inactivated in mouse two-cell embryos by competition with other heterologous enhancers. Mouse early one-cell embryos and late two-cell embryos were cultured in aphidicolin to arrest development when they entered S-phase. The test construct containing GT enhancer, pGT 5 Pyluc (25 µg/ml), produced~2.35ϫ10 5 RLU in the zygotic nuclei of S-phase-arrested two-and four-cell embryos. This was~500-fold more than pPyluc produced in these embryos. Each competitor plasmid was 200 µg/ml except for pSGVP (75 µg/ml) which was used only to provide GAL4:VP16 at saturating levels. pSVpro contained the SV40 promoter consisting of six tandem Sp1 DNA binding sites linked to a TATA box. pSVpro/enh contained the complete SV40 promoter and enhancer region. The total concentration of DNA in the microinjected solution was kept constant at 300 µg/ml in two-cell embryos by addition of the appropriate amount of pBR322. Each set of plasmid DNA was diluted into half before injecting them into the paternal pronucleus of one-cell embryos, to keep the total DNA concentration at 150 µg/ml. pGT 5 Pyluc produced~0.5ϫ10 5 RLU of luciferase activity in these embryos. This was~1.5-fold more than that produced by pPyluc under similar conditions. GAL4:VP16 (pSGVP). These controls were reproduced and compared with oocytes that had been preinjected with ES cell mRNA. The results revealed that ES cell mRNA expressed a factor that allowed the GAL4 enhancer to stimulate the tk promoter. Pre-injection of oocytes with ES cell mRNA, and not Escherichia coli tRNA, stimulated pGAL 9 tkluc 3.5-fold in the presence of pSGVP, or~25% of the maximum amount of enhancer stimulation one might expect based on the maximum ability of butyrate to stimulate tk promoter activity in oocytes (Figure 5 , Oocytes). ES cell mRNA did not stimulate the tk promoter in the absence of an enhancer. Injection delivered~0.5 pg of mRNA per cell, which is~2.5-fold more than the poly(A) ϩ RNA content of a two-cell embryo (Zimmerman and Schultz, 1994) . Since oocytes contain 2-to 3-fold more poly(A) ϩ RNA, the amount of ES cell mRNA delivered to oocytes was equivalent to the amount of endogenous mRNA already present. Higher concentrations of ES cell mRNA could not be tested, because they were toxic to the cells, but a 1:1 mixture of ES cell mRNA and E.coli tRNA gave~50% stimulation. Since E.coli tRNA alone had no effect, enhancer-specific stimulation was in proportion to the amount of ES cell mRNA provided. Therefore, these mRNA preparations provided one or more factors required The specificity of the enhancer-specific stimulation embryos were injected with either ptkluc or pGAL 9 tkluc plus sufficient observed by preinjecting ES cell mRNA into oocytes was amount of pSGVP as described in Figure 2 . Some injected ova were confirmed by repeating similar experiments in two-cell cultured in the presence of 2.5 mM butyrate. In some experiments, 2 pl of 500 µg/ml of ES cell mRNA, E.coli tRNA (Sigma), or a embryos ( Figure 5 , 2-Cell Embryos). As described before, mixture of ES cell mRNA and tRNA (1:1) was preinjected into the the activity of the tk promoter was repressed in cleavagecytoplasm of oocytes or two-cell embryos (both blastomeres) 1 h stage embryos, and this repression could be relieved either before either ptkluc or pGAL 9 tkluc ϩ pSGVP was injected into one of by addition of butyrate to the culture medium (Figures 1-the nuclei of these cells. Stimulation by Gal4-dependent enhancer in 3) or by linking the promoter to an active enhancer, such oocytes was marginal when mRNA and luciferase expression vectors were co-injected into the nuclei. ES cells were generated from mouse as the F101 enhancer or the GAL4-dependent enhancer blastocysts and propagated on lysed PMEF cells as feeder layer in in the presence of GAL4:VP16. When these controls were DME plus 15% heat-inactivated fetal bovine serum and in the reproduced and compared with two-cell embryos that had presence of 1000 U/ml ESGRO murine leukemia inhibitory factor to been preinjected with ES cell mRNA, the results revealed prevent them from differentiating. mRNA from ES cells was isolated using an RNA isolation kit from Stratagene.
that ES cell mRNA could not further stimulate either the Fig. 6 . The role of enhancers in relieving chromatin-mediated repression of promoters. Enhancer activity requires both sequence-specific transcription factors that bind to the enhancer and a unique coactivator that mediates interaction of the enhancer with one or more of the proteins that activate a promoter. Chromatin-mediated repression is absent from the paternal pronucleus of one-cell embryos, so that enhancers are dispensable under these conditions. Repression does occur in the maternal pronucleus of oocytes and one-cell embryos, and in the zygotic nuclei of cleavage-stage embryos as well as in later stages of development, but the enhancer-specific coactivator first appears in two-cell embryos. Thus, it is not until the major ZGE begins that enhancers can be utilized to relieve chromatin-mediated repression.
tk promoter alone (ptkluc), or the tk promoter in the function is developmentally acquired after formation of a two-cell embryo through the appearance of a unique presence of a functional GAL4 enhancer (pGAL 9 tkluc). E.coli tRNA also had no effect. Since two-cell embryos coactivator activity. A plasmid-encoded reporter gene injected into mamalready contained both promoter-and enhancer-specific factors, the additional factors provided by ES cell mRNA malian nuclei is subject to two competing reactions: assembly into an active transcription complex versus were apparently not needed.
assembly into a repressed chromatin state ( Figure 6 ). Thus, the fraction of active transcription complexes depends on Discussion the relative concentrations of the proteins that compose these two pathways. For example, histone H1 synthesis As a fertilized mouse egg develops into an adult animal, gene expression passes from a state in which all of the and core histone deacetylation promote formation of repressed chromatin, while basal level transcription factors zygote's genes are turned off (the one-cell embryo) to one in which zygotic genes can be activated selectively at together with sequence-specific DNA binding proteins that bind to promoters and enhancers facilitate formation of specific times and in specific cell types. Enhancers provide an important mechanism in this transition. However, our active transcription complexes (Workman and Buchman, 1993; Wolffe and Pruss, 1996) . This competition occurs knowledge of how enhancers and other transcriptional elements function has been limited to studies of viral and in most cell nuclei, but one exception is the paternal pronucleus of one-cell embryos. Here, the chromatin cellular genes in either cultured cells or cell extracts. Studies of transcription regulation as a function of mamformed is in an open configuration that allows formation of transcriptionally active initiation complexes without the malian development have been difficult due to the limited numbers and sizes of embryos available for biochemical need for an enhancer. Therefore, it is necessary for a 'zygotic clock' (described below) to delay transcription studies. One solution to this problem has been to microinject plasmid-encoded reporter genes in order to identify in these cells in order to prevent premature gene expression. On the other hand, in cleavage-stage embryos (e.g. requirements for specific cis-acting sequences and transacting factors that regulate DNA transcription and replictwo-and four-cell embryos) where ZGE begins during mouse development, injected DNA is rapidly converted ation at the beginning of mammalian development. This approach allows these processes to be characterized within into a repressed chromatin state, and enhancers are required to prevent formation of this repressed state at promoter the context of single living embryos as they undergo the transition from dependence on maternally inherited mRNA sites by interacting directly with one or more of the proteins that bind to promoters. The results presented here and proteins to dependence on ZGE. Utilizing this approach, we have confirmed our previous results suggest strongly that this interaction requires a specific coactivator, in addition to proteins that bind to specific (Majumder et al., 1993) showing that enhancers provide a special function in vivo that is distinct from that of sequences that define the enhancer elements. However, once chromatin has repressed a promoter, DNA replication promoters, and have extended them to reveal that enhancer may be required to disrupt this chromatin structure and gene repression (Bouvet et al., 1994; Juan et al., 1994) . These effects are consistent with the observation that allow enhancer recognition proteins to bind to promoter recognition proteins. DNA replication would then provide transcriptionally active genes are enriched in hyperacetylated core histones and deficient in histone H1 (Tazi and a mechanism for reprogramming gene expression.
The enhancer-specific coactivator mediates the interBird, 1990; Hebbes et al., 1992) . Treatment of mouse oocytes and early embryos with optimum amounts of action of enhancers with promoters presumably by direct interaction between sequence-specific transcription factors butyrate stimulates the activity of plasmid-encoded promoters injected into the maternal nuclei of oocytes, activthat bind to the enhancer and to the transcription complex that forms at the promoter. This interaction has been ated eggs, and one-cell embryos, or into any nucleus in two-cell embryos, regardless of its nuclear origin or ploidy, demonstrated in previous studies on promoter activity during mouse development (Majumder and DePamphilis, but butyrate does not stimulate promoter activity in the paternal pronuclei in one-cell embryos (Majumder et al., 1994a) . In differentiated cells, enhancer stimulation of the tk promoter requires a TATA box, a requirement that Wiekowski et al., 1993) . Thus, butyrate stimulates promoter activity in nuclei that exhibit repression, and appears to be a general feature of RNA polymerase II promoters, while prior to cell differentiation, in cleavagedoes not stimulate promoter activity in nuclei that do not exhibit repression. The fact that butyrate has opposite stage embryos, enhancer stimulation of the tk promoter requires an upstream Sp1 binding site. Since the same effects on the maternal and paternal pronuclei in a onecell embryo strongly suggests that these effects are directed transcription factors (e.g. TEF-1 and GAL4:VP16) that can function in the capacity of a promoter in oocytes or at the structure of chromatin assembled onto the injected plasmid, rather than by changes in transcription factors. at the beginning of ZGE in S-phase-arrested one-cell embryos cannot function in the capacity of an enhancer Moreover, butyrate and other histone deacetylase inhibitors simply stimulate synthesis of transcription-dependent prountil the two-and four-cell stages in development, separate coactivators specific for either promoter function (short teins at the onset of ZGE without changing the pattern of protein synthesis (Wiekowski et al., 1993; Worrad et al., range) or enhancer function (long range) must exist. The fact that some activation domains can function only 1995). More recently (Wiekowski et al., 1997) , changes have been identified in the synthesis and modification of proximal to the transcription site while others can function in both proximal and distal positions (Seipel et al., 1992, chromatin-bound histones that are consistent with this hypothesis. The appearance of chromatin-mediated repres-1994) is consistent with the conclusion that proximal and distal interactions are mediated by different coactivators.
sion of promoters at the beginning of mouse development was consistent with changes in the production of histone Previous studies (Ge and Roeder, 1994; Kretzschmar et al., 1994) have revealed the presence of general coactivators H1 and acetylation of core histones: repression was greatest when all five histones were being synthesized and such as PC4 (p15) that are not obligatory for RNA polymerase II basal level transcription, but that facilitate core histones were not hyperacetylated. In vitro, enhancers do not stimulate transcription unless the DNA substrate transcription through direct interaction between transcription factors that bind at sites upstream but proximal to is organized into chromatin and the chromatin is condensed by addition of histone H1 (reviewed in Majumder et al., the TATA box (e.g. Gal4-based acidic activators) and components of TFIID (e.g. TFIIA). Such coactivators can Paranjape et al., 1994) . However, deletion of the histone H1 gene in Tetrahymena reveals that linker histone stimulate promoter activity in the absence of chromatin assembly in in vitro reactions. Whether or not the same H1 regulates specific gene expression but not global transcription in vivo (Shen and Gorovsky, 1996) . Thus, coactivator can also mediate the distal action of an enhancer remains to be determined. The nature of the other 'linker' proteins may also play a role in chromatinmediated repression. enhancer-specific coactivator activity described here and its role, if any, in activating promoter activity from a How do chromatin-mediated repression and enhancer utilization help to regulate gene expression at the beginning proximal site remain to be determined. It appears to be required for the activity of many, apparently unrelated, of mammalian development? The onset of transcription during mouse development is regulated by a time-dependenhancers and as such could serve as a master switch to regulate the activity of several different genes at one time ent mechanism (zygotic clock), and takes place~40 h post-fertilization, a time when a normally developing by determining when and under what conditions enhancers could be utilized to relieve chromatin-mediated repression.
embryo is at the two-cell stage. This stage of development also coincides with the onset of major chromatin repression The repression observed at the beginning of mouse development appears to be mediated by chromatin strucof promoters . The paternal genome in sperm comes with protamines, whereas ture, because it can be relieved either by treating the cells with butyrate, or, in cleavage-stage embryos (two or more the maternal genome in eggs comes with a normal complement of core histones (Zirkin et al., 1989; Nonchev and cells) , by linking the promoter or replication origin to an embryo-responsive enhancer (Majumder and DePamphilis, Tsanev, 1990) . After fertilization, they undergo chromatin remodeling to establish the zygotic genome at the two-1995; Wiekowski et al., 1997) . Butyrate increases the fraction of hyperacetylated core histones by inhibiting cell stage. This process of remodeling probably generates DNA that is not complexed with either histones or histone deacetylation, and thereby stimulates expression of both cellular and plasmid-encoded genes (Turner and protamines (Rodman et al., 1981) , and exposes promoters to transcription factors. Thus, the zygotic clock may O 'Neill, 1995) . Hyperacetylated core histones increase the accessibility of chromatin to transcription factors and provide a mechanism to ensure that no spurious transcription occurs during the remodeling period. On the other reduce the affinity of oligonucleosomes for histone H1, an important contributor to chromatin condensation and hand, after the zygotic remodeling, the chromatin-mediated promoter (ptkluc) or the tk promoter coupled to the polyomavirus (Py) repression of most promoters in two-cell embryos may F101 enhancer (pF101tkluc) were previously used for studying enhancer provide a mechanism for enhancer-mediated tissue-specific function in mouse oocytes and embryos (Majumder et al., 1993) .
transcription of genes during development and growth.
pSVCAT expresses the bacterial CAT gene driven by the SV40 promoter/ Delaying expression of the enhancer-specific coactivator enhancer, pSGVP encodes Gal4:VP16 fusion protein, pMEX4 expresses herpes simplex virus ICP4 driven by its natural promoter (Resnick et al., prior to ZGE provides an additional mechanism for pre- 1990; Seshagiri et al., 1992; Schultz, 1993) . Whether or Plasmid DNA was prepared in 10 mM Tris-HCl pH 7.6 and 0.25 mM not repression of promoter activities appears at the two-EDTA (Majumder, 1996) to the desired concentration, and~2 pl was injected into one-cell embryos 22-28 h post-hCG treatment, and into cell stage in these mammals, or is delayed until the same two-cell embryos 44-48 h post-hCG. Embryos surviving injection were stage that transcription begins, remains to be seen. The assayed for firefly luciferase or bacterial CAT activities.
S-phase of a two-cell mouse embryo appears equivalent to the sixth cleavage stage in Xenopus, where synthesis
Firefly luciferase assay of heterogeneous, non-ribosomal mRNA is first detected.
Firefly luciferase activity was assayed in individual embryos as previously
The G 2 -phase of a two-cell mouse embryo appears equivadescribed Majumder, 1996 embryos could vary as much as 1000-fold (Majumder, 1996) , the mean 1987; Shiokawa et al., 1989) . The activity of promoter/ value obtained from several independent experiments was reproducible enhancer sequences injected into Xenopus eggs is generally to within 13-25%. Moreover, the relative activity between different types of embryos and different promoters was always reproducible, even delayed until the MBT, although they appear to exhibit a when DNA injection was performed by different people.
low but constant rate of gene expression per cell prior to the MBT (Shiokawa et al., 1990) . Activation of transcription at promoters in two-cell mouse embryos. The MBT also at 16 000 g for 5 min at 4°C, and the supernatant assayed for CAT marks the appearance of histone H1-mediated repression activity as described by Sambrook et al. (1989) . The fraction of of oocyte-specific genes such as 5S RNA (Wolffe, 1989;  [ 14 C]acetylchloramphenicol was measured by using a Betascope 603 Ohsumi and Katagiri, 1991) , analogous to the repression (Betagen) to collect at least 100 000 emissions. These numbers were observed upon formation of two-cell mouse embryos. Furthermore, analogous stage-specific acquisition of specific transcriptional coactivators for enhancer function
Assays of promoter activity in transfected cells
may also occur at the MBT (Xu et al., 1994) .
Luciferase assays were performed on 50 µl portions of cell extract prepared in CEB (0.1M sodium phosphate pH 7.8, 1 mM dithiothreitol, 0.1% Triton X-100) under the same conditions used for extracts of
Materials and methods
mouse oocytes and embryos as described previously . CAT assays were also carried out on 50 µl portions of cell extract Mouse embryos and oocytes prepared in CEB. Extracts were incubated with 4 mM acetyl coenzyme Isolation, culture and injection of CD-1 mouse embryos and oocytes A, 0.05 µCi [ 14 C]chloramphenicol (Amersham), 0.5 M Tris-HCl pH 8.0 were carried out as previously described (Majumder et al., 1993;  Miranda at 37°C for 1 h, and then extracted with 900 µl ethyl acetate and and Majumder, 1996) . Growing lyophilized. The pellet was dissolved in 25 µl ethyl acetate, chromatooocytes were obtained from 13-to 14-day-old females, and were cultured graphed on silica gel and analyzed by autoradiography (Sambrook in the presence of 100 µg/ml dibutyryl-cAMP to prevent meiotic et al., 1989) . maturation. Growing oocytes obtained from 2-to 3-week-old prepubertal mice are more transcriptionally active than mature oocytes obtained from older mice (Worrad et al., 1994) . Fertilized eggs (one-cell embryos)
Embryonic stem cells were isolated from 8-to 10-week-old pregnant females 17 h after human Embryonic stem (ES) cells were generated from mouse blastocysts as chorionic gonadotrophin hormone (hCG) was injected and were cultured described by Abbondanzo et al. (1993) . ES cells were grown on lysed in the presence of 4 µg/ml aphidicolin (Boehringer Mannheim) to arrest PMEF cells as feeder layer in DME (Specialty Media) plus 15% heattheir development at the beginning of S-phase. Two-cell embryos were inactivated fetal bovine serum and in the presence of 1000 U/ml ESGRO isolated 40-42 h post-hCG injection, at which time they had completed murine leukemia inhibitory factor (Gibco-BRL) to prevent them from S-phase. When these embryos are cultured in the presence of aphidicolin, differentiating. mRNA from ES cells for initial experiments were carried they undergo cleavage into four-cell embryos and are then arrested at out using a commercially available RNA isolation kit (Stratagene). These the beginning of S-phase. In the absence of aphidicolin, most injected experiments were repeated using ES cell mRNA. two-cell embryos develop into morula by 44 h.
Plasmids

